Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) | Date | Article Title |
Journal |
|---|---|---|---|
|
Omar Abdel-Rahman |
March 2019 | Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials | Clinical Colorectal Cancer |
|
Omar Abdel-Rahman |
December 2019 | Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials | Clinical Colorectal Cancer |
|
Justyna Mierzynska, Mekdes Taye, Madeline Pe, Corneel Coens, Francesca Martinelli, Katarzyna Pogoda, Galina Velikova, Vesna Bjelic-Radisic, Fatima Cardoso, Etienne Brain, Michail Ignatiadis, Martine Piccart, Geertjan Van Tienhoven, Robert Mansel, Hans Wildiers, Andrew Bottomley, on behalf of EORTC and EORTC Breast Cancer Group |
December 2019 | Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer | European Journal of Cancer |
|
Kaitlyn Johnson, Axel Gomez, Jackson Burton, Douglas White, Arijit Chakravarty, Annette Schmid, Dean Bottino |
November 2018 | Directional Inconsistency Between Response Evaluation Criteria in Solid Tumors (RECIST) Time to Progression and Response Speed and Depth | European Journal of Cancer |
|
Tao Wang, Rong Lu, Sunny Lai, Joan H. Schiller, Fang Liz Zhou, Bo Ci, Stacy Wang, Xiaohan Gao, Bo Yao, David E. Gerber, David H. Johnson, Guanghua Xiao, Yang Xie |
February 2019 | Development and Validation of a Nomogram Prognostic Model for Patients with Advanced Non-Small-Cell Lung Cancer | Cancer Informatics |
|
Omar Abdel-Rahman, Winson Y.Cheung |
December 2018 | Impact of Prior Local Treatment on the Outcomes of Metastatic Hormone-Sensitive Prostate Cancer: Secondary Analysis of a Randomized Controlled Trial | Clinical Genitourinary Cancer |
|
Eric V.Li, Mohammad R.Siddiqui, Adam B.Weiner, Anna E.Prizment, Charles J.Ryan, Alicia K.Morgans |
March 2021 | Efficacy and adverse events of docetaxel for metastatic, hormone-sensitive prostate cancer among elderly men: post-hoc analysis of CHAARTED trial | Clinical Genitourinary Cancer |
|
Omar Abdel-Rahman |
February 2019 | Impact of Diabetes on the Outcomes of Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel: A Pooled Analysis of Three Phase III Studies | Clinical Genitourinary Cancer |
|
Louis Dron, Shirin Golchi, Grace Hsu, Kristian, Thorlund |
September 2019 | Minimizing Control Group Allocation in Randomized Trials Using Dynamic Borrowing of External Control Data – An Application to Second Line Therapy for Non-Small Cell Lung Cancer | Contemporary Clinical Trials Communications |
|
Fionán Donohoea, Yvonne O'Mearaa, AidinRoberts, Louise Comerford, Catherine M. Kelly, JaniceM. Walshe, Michelle Peate, Marth aHickey, Donal J.Brennan |
November 2021 | The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study | Contemporary Clinical Trials Communications |
|
Steven B.Cohen, Jennifer Unangst, Feng Yu |
November 2020 | Enhancing the analytic utility of clinical trial data to inform health disparities research | Contemporary Clinical Trials Communications |
|
Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron C. Tan, Stephen J. Bagley, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang, Rifaquat Rahman, Evanthia Galanis, Alireza Mansouri, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John H. Sampson, John Simes, Donald A. Berry, Gelareh Zadeh, Tim F. Cloughesy, Minesh P. Mehta, Steven Piantadosi,Michael Weller, Amy B. Heimberger |
September 2021 | Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma | American Association for Cancer Research |
|
Jiawei Zhou, Yutong Liu, Yubo Zhang, Quefeng Li and Yanguang Cao |
November 2019 | Modeling tumor evolutionary dynamics to predict clinical outcomes for patients with metastatic colorectal cancer; a retrospective analysis | American Association for Cancer Research |
|
Omar Abdel-Rahman, Winson Y. Cheung |
January 2018 | External validation of the prostascore model inpatients with metastatic hormone-sensitive prostate cancer recruited to the CHAARTED study | BJU International |
